Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

The biotechnology sector has experienced a jolt of volatility over the past few days, spearheaded by the dramatic price ...

WuXi AppTec (Shanghai, China) has sold off two US/UK businesses in February and March, it revealed in its annual results on ...

The drug and biotech sector has recovered over the past couple of months, following a slow start to the year, primarily due ...

MM+M Agency 100 issue is nominated for Best Single Issue of a Tabloid/Newspaper/Magazine for a brand with revenue between $3 ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

CorMedix (CRMD) delivered earnings and revenue surprises of 29.41% and 1.39%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Two UIC professors list their questions for the man set to lead "the crown jewel” of American biomedical science.

International private equity firm Cinven has completed its previously announced sale of an indirect minority stake in SYNLAB, a leader in medical diagnostic services and specialty testing in Europe, ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc.

Treasurer Jim Chalmers warned there would be little, if anything, new in this document given the government had planned to ...